Not to mention that Shire is presenting at the Deutsche Bank 41st Annual Healthcare Conference on Weds, May 4 from 10A (EST) to 10:35A (EST) in Boston. Jeff Poulton (CFO) and Howard Mayer (Head of Clinical Development/R&D) presenting. It'd be nice if they had an update for their entire pipeline and not just a handful. I wish I could attend just to ask Mayer about SHP622.
I wonder if it'll be awkward when AbbVie has their presentation immediately after them. Ice breaker has to be, "Remember that time you were going to buy us out, only to have the deal terminated and you paying us a $1.64B fee? Good times."
News 
Market Data 
Discover 
